Hundreds of thousands of people continue to die from advanced HIV, also known as AIDS, because countries are still ill-equipped to detect and treat people suffering through advanced stages of the disease, according to a new report re
The World Health Organization recommends "same-day" initiation of antiretroviral therapy (ART) for HIV patients who are eligible and ready. Identifying efficient, safe, and feasible procedures for determining same-day eligibility and readiness is now a priority. The Simplified Algorithm for Treatment Eligibility (SLATE) study evaluated a clinical algorithm that allows healthcare workers to determine eligibility for same-day treatment and to initiate ART at the patient’s first clinic visit.
Half of those attending HIV clinics in South Africa and Kenya were eligible to start HIV treatment after simple checks that could be performed by any healthcare worker, and same-day treatment initiation modestly improved the uptake of antiretroviral therapy (ART), results of a randomised trial pu
The third blog in this ACCESS PrEP blog series addresses health providers’ experiences with oral PrEP services. It explores their knowledge of oral PrEP and concerns about increased risky behaviour. Health providers also expressed concern about the challenges clients faced when accessing oral PrEP and the barriers to uptake, adherence and continuation.
This narrative, the second in the ACCESS PrEP blog series, focuses on PrEP-related side effects. It highlights the determination of some clients to continue using oral PrEP despite the side effects they were experiencing.
This blog is the first in the ACCESS blog series and it gives an overview of the study findings. It explores the motivations that made clients decide to start, continue or stop using oral PrEP, as well as what made certain clients decide not to start taking oral PrEP at all.